Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

View:
Post by Mrlucky on Jan 25, 2023 5:39pm

Sami

  • The Company is working with Baxter on a sub-study to obtain FDA approval for hemoperfusion for Baxter’s Prismax device; the Prismax, with its leading installed base, is anticipated to be the primary device utilized for PMX treatments on commercial launch.
wasn't Sami going to be the future for PMX treatments....perhaps this is where the fallout with Infomed began
Comment by BayStreetWild on Jan 25, 2023 5:43pm
it probably started with them not being able to find a partner(suitable buyer) or financing to run the trial.   
Comment by mercedesman on Jan 25, 2023 5:51pm
Excellent point.  Prismax approval ensures more immediate, out of the gate usage of PMX post fda approval ( if it happens) ... especially with their large pre-installed base.  perhaps Infomed is not thrilled, but I question their ability to deliver SAMIs on a big scale for the US. I suspect they need to show that they have sufficient capacity to deliver both SAMI and DIMI on a ...more  
Comment by hmmmmmmmm on Jan 25, 2023 5:55pm
Great point McShill, Infomed has much to do- good thing we gave them control of DIMI/ SAMI.. home dialysis use is probably a silly fad- right?
Comment by mercedesman on Jan 25, 2023 6:14pm
To think at one time I had high hopes for you Hmmmm ? Your souring on your investment has impaired your judgement it seems.  Exactly! ...it IS a good thing Infomed has agreed to take back the reins rather than expecting Spectral to carry the ball for another year or so ( and needing to raise millions)  HHD ( Ala DIMI) is more viable than ever. Huge increases in kidney decease ...more  
Comment by hmmmmmmmm on Jan 25, 2023 6:37pm
Ha. My judgement has been clear and steady- I believe in PMX, I believe in DIMI/SAMI. But I don't believe in management. Enrolling 1-2 patients a month is a disaster for this company. Giving away control of DIMI/SAMI is lousy for this company. You on the other hand spend your days trying to hide these simple facts - in an attempt, I guess to persuade new investors? Ha.  So, that' ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities